Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.15017DOI Listing

Publication Analysis

Top Keywords

suppression podoplanin
4
podoplanin expression
4
expression differentiation
4
differentiation epidermal
4
epidermal keratinocytes
4
suppression
1
expression
1
differentiation
1
epidermal
1
keratinocytes
1

Similar Publications

Cancer-associated fibroblasts (CAFs) are intrinsic components of the tumor microenvironment that promote cancer progression and metastasis. Through an unbiased integrated analysis of gastric tumor grade and stage, we identified a subset of proangiogenic CAFs characterized by high podoplanin (PDPN) expression, which are significantly enriched in metastatic lesions and secrete chemokine (CC-motif) ligand 2 (CCL2). Mechanistically, PDPN(+) CAFs enhance angiogenesis by activating the AKT/NF-κB signaling pathway.

View Article and Find Full Text PDF

Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor.

J Respir Biol Transl Med

December 2024

Department of Surgery, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.

Background: Deficiency of surfactant protein-C (SPC) increases susceptibility to lung infections and injury, and suppressed expression of SPC has been associated with the severity of acute respiratory distress syndrome (ARDS). Alveolar type 2 epithelial cells (AT2) are critical for maintenance and repair of the lung. However, the role of the SPC in the regulation of AT2 cell lineage and the underlying mechanisms are not completely understood.

View Article and Find Full Text PDF

Nontransformed cells form heterotypic cadherin junctions with adjacent transformed cells to inhibit tumor cell growth and motility. Transformed cells must override this form of growth control, called "contact normalization", to invade and metastasize during cancer progression. Heterocellular cadherin junctions between transformed and nontransformed cells are needed for this process.

View Article and Find Full Text PDF

Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.

Proc Natl Acad Sci U S A

April 2024

Department of Pathology and Genomic Medicine, and the Translational Cellular Oncology Program, Sidney Kimmel Cancer Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107.

Article Synopsis
  • Decorin is a special type of protein made by cells in tumors that can stop cancer cells from growing by affecting certain signals in the body.
  • Scientists found that when decorin is given to mice with breast cancer, it reduces the development of lymphatic vessels, which help tumors spread.
  • The research suggests that decorin could be a new treatment to slow down or stop the growth of breast cancer by blocking these pathways.
View Article and Find Full Text PDF
Article Synopsis
  • Maackia amurensis lectins, specifically M. amurensis seed lectin (MASL), bind to sialic acid residues on proteins, showing potential to reduce inflammation in arthritic cells and inhibit tumor growth and movement.
  • The study characterized MASL into two groups based on its ability to form dimers, with MASL having unique isoforms and glycosylation sites that significantly impact its function and interaction with the podoplanin (PDPN) receptor.
  • Results indicate that MASL exhibits strong binding to PDPN and can effectively inhibit the growth and motility of oral squamous cell carcinoma (OSCC) cells, highlighting its potential use as an antic
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!